PharVision Advisers’s APA Corp APA Stock Holding History

PharVision Advisers’s Portfolio APA Stock Details APA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-15,466	Closed	-$357K	–	277
2024 Q4	$357K	Buy	+15,466	New	+$362K	0.3%	103

Other funds holding APA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SCM

Smead Capital Management Phoenix, Arizona $4.6B AUM 27.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PharVision Advisers's APA Position: Q1 2025 in Review

PharVision Advisers sold out of APA Corp (APA) in Q1 2025, closing a stake of 15,466 shares — an estimated $357K sold.

PharVision Advisers first reported a position in APA in Q4 2024 and held it in 1 quarter. The position peaked at $357K in Q4 2024. 609 funds tracked by Wall St. Rank hold APA as of Q1 2025.

PharVision Advisers reported no remaining APA Corp position as of Q1 2025 after selling out during the quarter.
PharVision Advisers sold 15,466 APA Corp shares in Q1 2025, an estimated $357K.
PharVision Advisers first reported a position in APA Corp in Q4 2024 and held it in 1 quarter.
PharVision Advisers's APA Corp position peaked at $357K in Q4 2024.
609 funds tracked by Wall St. Rank held APA Corp as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.